| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Revenue | $25.1M | +22.4% |
| Cost of Revenue | $11.4M | +10.1% |
| Gross Profit | $13.7M | +35.1% |
| R&D Expense | $19.9M | +24.6% |
| SG&A Expense | $11.2M | +4.3% |
| Operating Income | -$17.5M | -61.3% |
| Pre-tax Income | -$13.4M | -27.3% |
| Income Tax | -$132K | -201.5% |
| Net Income | -$13.2M |
| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $67.2M | +400.3% |
| Accounts Receivable | $4.2M | +33.7% |
| Inventory | $4.1M | +4.8% |
| Current Assets | $79.2M | +237.6% |
| Total Assets | $98.0M | +126.1% |
| Current Liabilities | $9.2M | +30.0% |
| Total Liabilities | $16.2M | +7.3% |
| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.9M | -22.7% |
| Capital Expenditures | $486K | +980.0% |
| Investing Cash Flow | -$486K | -104.3% |
| Financing Cash Flow | $70.2M | — |
| Free Cash Flow | -$16.4M | -26.0% |
| -24.5% |
| EPS (Basic) | -$0.42 | +0.0% |
| EPS (Diluted) | -$0.42 | +0.0% |
| Stockholders' Equity |
| $81.8M |
| +189.7% |